Joann P. Palma

ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models

Cherrie K. Donawho, Yan Luo, Yanping Luo et al. · Clinical Cancer Research · 2007 · 773 citations · Full text

Medicine, Oncology, Pharmacology +15

LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates

James W. Purcell, Sonia G. Tanlimco, Jonathan A. Hickson et al. · Cancer Research · 2018 · 199 citations

Medicine, Cancer Biology, Oncology +17

Iniparib Nonselectively Modifies Cysteine-Containing Proteins in Tumor Cells and Is Not a <i>Bona Fide</i> PARP Inhibitor

Xuesong Liu, Yan Shi, David Maag et al. · Clinical Cancer Research · 2011 · 175 citations · Full text

Medicine, Oncology, Pharmacology +11

ABBV-399, a c-Met Antibody–Drug Conjugate that Targets Both <i>MET</i> –Amplified and c-Met–Overexpressing Tumors, Irrespective of <i>MET</i> Pathway Dependence

Jieyi Wang, Mark G. Anderson, Anatol Oleksijew et al. · Clinical Cancer Research · 2016 · 140 citations · Full text

Medicine, Oncology, Pharmacology +16

ABT-888 Confers Broad <i>In vivo</i> Activity in Combination with Temozolomide in Diverse Tumors

Joann P. Palma, Yichun Wang, Luis E. Rodrı́guez et al. · Clinical Cancer Research · 2009 · 139 citations

Medicine, Oncology, Pharmacology +16